Levocabastine is a second-generation antihistamine mainly used to treat symptoms of allergic conjunctivitis and allergic rhinitis. Developed in the late 20th century and introduced in the early 1990s, it works by blocking H1 histamine receptors, helping reduce itching, redness, and sneezing. It is commonly used in topical forms like eye drops and nasal sprays, providing fast relief with minimal systemic side effects.

BRAND NAMES

  • Livostin (commonly used for both eye drops and nasal spray, originally developed by Janssen Pharmaceutica).

MECHANISM OF ACTION

Levocabastine works by selectively blocking H1 histamine receptors, preventing histamine from triggering allergic symptoms like itching, redness, and sneezing. It is mainly used in eye drops and nasal sprays, giving fast local relief with minimal systemic side effects.

PHARMACOKINETICS

Absorption

Levocabastine is poorly absorbed systemically when used topically as eye drops or nasal spray. Any small amount that is absorbed enters the bloodstream slowly and at low levels, resulting in minimal systemic exposure and limited distribution beyond local tissues.

Distribution

Levocabastine has a moderate volume of distribution (~1–2 L/kg), indicating that it distributes mainly within body fluids with limited penetration into deep tissues. Since it is usually administered as an eye drop or nasal spray, most of the drug remains localized at the site of application, with minimal systemic absorption. It also shows moderate plasma protein binding and poor entry into the brain, resulting in fewer systemic and sedative effects. 

Metabolism

 Levocabastine undergoes very minimal metabolism, with most of the drug remaining unchanged in the body. It is not significantly processed by liver enzymes, and due to its mainly topical use, only small amounts reach systemic circulation. This limited metabolism helps reduce the risk of drug interactions and ensures a predictable pharmacological effect. 

Elimination

 Levocabastine is eliminated mainly through the kidneys in unchanged form. Only a small portion is metabolized, so most of the drug is excreted as the original compound in urine. It has a relatively long terminal half-life, but because it is used topically (eye drops or nasal spray), systemic accumulation is minimal. This renal excretion pattern helps maintain its safety and low risk of systemic side effects. 

PHARMACODYNAMICS

Levocabastine is a selective H1 receptor antagonist that blocks the action of histamine at peripheral H1 receptors. This prevents allergic symptoms such as itching, redness, sneezing, and watery eyes. It acts locally in the eye and nasal mucosa with rapid onset and has minimal sedative effects due to poor penetration into the central nervous system. 

ADMINISTRATION

 Levocabastine is mainly given by the topical route as eye drops or nasal spray for allergic conditions. It is usually used twice daily to relieve symptoms such as itching, redness, sneezing, and watery discharge. Since it acts locally with minimal systemic absorption, it produces fewer side effects and provides quick relief at the site of allergy. 

DOSAGE AND STRENGTH

 Levocabastine is commonly available as an ophthalmic solution (eye drops) 0.05% (0.5 mg/mL) and a nasal spray 0.05%.The usual dosage is 1 drop in each eye twice daily for allergic conjunctivitis, and 1 spray in each nostril twice daily for allergic rhinitis. Dosage may be adjusted based on symptom severity and medical advice, but it is generally used regularly for effective control of allergy symptoms.

 DRUG INTERACTIONS

 Levocabastine has minimal drug interactions because it is mostly used topically and undergoes little systemic metabolism.It does not significantly affect liver enzymes, so major pharmacokinetic interactions are rare. However, combining it with other sedating drugs may rarely increase drowsiness in sensitive patients.

 FOOD INTERACTIONS

 Levocabastine has no significant food interactions because it is mainly used as an eye drop or nasal spray and shows minimal systemic absorption. Food does not affect its absorption, distribution, or effectiveness. Therefore, it can be used without regard to meals, and no dietary restrictions are usually required. 

CONTRAINDICATIONS

 Levocabastine is contraindicated in patients with known hypersensitivity or allergy to levocabastine or any component of the formulation. It should be used cautiously in individuals with severe eye or nasal infections unless advised by a physician, as it may mask symptoms. Otherwise, due to its topical use and low systemic absorption, it has very few absolute contraindications. 

SIDE EFFECTS

 • Eye irritation 

• Burning or stinging sensation 

• Itching or redness of eyes 

• Nasal irritation

 • Nasal dryness

 • Sneezing

 • Headache

 • Rare mild drowsiness

 OVER DOSE

 • Rare due to topical use and low systemic absorption 

• Increased eye or nasal irritation 

• Burning or redness at application site

 • Dryness of eyes or nose

 • Headache

 TOXICITY

 Levocabastine has very low toxicity because it is mainly used topically with minimal systemic absorption. Overexposure may cause mild local irritation like burning, redness, or dryness, and rarely headache or drowsiness. Serious toxic effects are uncommon, and treatment is usually supportive.

Image
slide.1
CAS Number
Levocabastine STD-79516-68-0; 79547-78-7(HCl Salt): IMP-A-1348822-76-3: IMP-B-NA: IMP-E-NA: IMP-J-NA: IMP-K-NA
CAS Number
79516-68-0
Alternate CAS Number
79547-78-7(HCl Salt)